Zobrazeno 1 - 10
of 150
pro vyhledávání: '"Jinlan Pan"'
Autor:
Mo Zhou, Yan Chen, Yanlei Gong, Mingqing Zhu, Jiannong Cen, Jinlan Pan, Lingzhi Yan, Jingjing Shang, Song Jin, Xiaolan Shi, Weiqin Yao, Shuang Yan, Depei Wu, Suning Chen, Chengcheng Fu, Li Yao
Publikováno v:
Discover Oncology, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Purpose To evaluate the efficacy of next-generation sequencing (NGS) in minimal-residual-disease (MRD) monitoring in Chinese patients with multiple myeloma (MM). Methods This study analyzed 60 Chinese MM patients. During MRD monitoring in th
Externí odkaz:
https://doaj.org/article/4c49dee806fa4d6e9bcfdf495e6537b9
Autor:
Mengyun LI, Qingya Cui, Huiying Qiu, Lingling Liu, Zheng LI, Sifan Chen, Yan Yu, Jiannong Cen, Hongjie Shen, Jinlan Pan, Mingqing Zhu, Xiaming Zhu, Ying Wang, Suning Chen, Depei Wu, Xiaowen Tang
Publikováno v:
HemaSphere, Vol 7, p e117650f (2023)
Externí odkaz:
https://doaj.org/article/b234277dee6946308d3dba2c6abba183
Publikováno v:
Hematology, Vol 27, Iss 1, Pp 499-505 (2022)
Purpose Cytogenetically normal acute myeloid leukemia (CN-AML) is a heterogeneous disease with variable clinical outcomes. The identification of potential biomarkers to better classify the patients with unfavorable prognoses who may require more aggr
Externí odkaz:
https://doaj.org/article/5596af232b9e4b49bd9be084c1adf407
Autor:
Xuanqi Cao, Haiping Dai, Qingya Cui, Zheng Li, Wenhong Shen, Jinlan Pan, Hongjie Shen, Qinfen Ma, Mengyun Li, Sifan Chen, Juncheng Chen, Xiaming Zhu, Huimin Meng, Lin Yang, Depei Wu, Xiaowen Tang
Publikováno v:
Experimental Hematology & Oncology, Vol 11, Iss 1, Pp 1-5 (2022)
Abstract Relapsed/refractory acute myeloid leukemia (AML) patients generally have a dismal prognosis and the treatment remains challenging. Due to the expression of CD7 on 30% AML and not on normal myeloid and erythroid cells, CD7 is an attractive ta
Externí odkaz:
https://doaj.org/article/131d1295c28b4fa7ae29c0ff1a185f32
Autor:
Hongying You, Song Jin, Chunxiao Wu, Qingqing Wang, Shuang Yan, Weiqin Yao, Xiaolan Shi, Jingjing Shang, Lingzhi Yan, Ying Yao, Jing Wang, Panfeng Wang, Jinlan Pan, Depei Wu, Chengcheng Fu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Objective1q21 gain/amplification (1q21+) is a common abnormal karyotype in multiple myeloma, and its proportion in Chinese patients is much higher. If 1q21+ is included as one of the poor prognostic factors, it will greatly increase the proportion of
Externí odkaz:
https://doaj.org/article/9290813f7d214f85ae51ca8eb3bc0635
Autor:
Yingxin Sun, Yifeng Cai, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Qian Wang, Depei Wu, Suning Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Several clinical trials have shown promising efficacy of pegylated interferon (Peg-IFN) in the first- and second-line polycythemia vera (PV) and essential thrombocythemia (ET). However, the efficacy and safety of Peg-IFN in the real world have rarely
Externí odkaz:
https://doaj.org/article/ce0535500be841c8a30db5fee9b3d71f
Autor:
Yingxin Sun, Yifeng Cai, Jia Chen, Jiannong Cen, Mingqing Zhu, Jinlan Pan, Depei Wu, Aining Sun, Suning Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Myeloproliferative neoplasm (MPN) with PCM1-JAK2 rearrangement is a rare disease with poor prognosis and lacks uniform treatment guidelines. Several studies confirmed the efficacy of ruxolitinib in hematological malignancies with PCM1-JAK2 fusion, bu
Externí odkaz:
https://doaj.org/article/d0907f0146914aeba60588a5bfe088ef
Autor:
Yan Yu, Zhao Zeng, Jundan Xie, Qiongyu Lu, Wenzhi Cai, Ruixi Zhang, Jinlan Pan, Yun Zhao, Aining Sun, Huiying Qiu, Suning Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PAX5 plays a critical role in B-cell precursor development and is involved in various chromosomal translocations that involve the fusion of a portion of PAX5 to at least 49 different partners reported to date. Here, we identified a novel PAX5 fusion
Externí odkaz:
https://doaj.org/article/5f4e9186a57c4db2b816725d747f1237
Autor:
Lijun Wen, Yang Xu, Li Yao, Nana Wang, Qinrong Wang, Tianhui Liu, Jinlan Pan, Jiannong Cen, Huifeng Zhou, Miao Miao, Yang W. Shao, Xiaonan Wang, Xiaoxia Wang, Changgeng Ruan, Depei Wu, Suning Chen
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Externí odkaz:
https://doaj.org/article/2b15737a9feb40f0b7f7301deb4d5bfb
Autor:
Qian Wang, Huiying Qiu, Hui Jiang, Lili Wu, Shasha Dong, Jinlan Pan, Wenjuan Wang, Nana Ping, Jing Xia, Aining Sun, Depei Wu, Yongquan Xue, Hans G. Drexler, Roderick A. F. MacLeod, Suning Chen
Publikováno v:
Haematologica, Vol 96, Iss 12 (2011)
Background Mutations in the PHF6 gene were recently described in patients with T-cell acute lymphoblastic leukemia and in those with acute myeloid leukemia. The present study was designed to determine the prevalence of PHF6 gene alterations in T-cell
Externí odkaz:
https://doaj.org/article/9a7f50fc71e7467bbcbe2939fa1d8a00